$WTO
UTime Ltd Stock $wto

$wto Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 20-F Financial Statement

#000121390023064327 Filed on August 08, 2023

Income Statement

Concept	2023 Q3	2023 Q1	2023
Revenue	$83.93M	$200.5M	$29.18M
YoY Change	-34.33%	-27.21%	-32.75%
Cost Of Revenue	$79.98M	$170.5M	$24.81M
YoY Change	-30.54%	-34.86%	-39.82%
Gross Profit	$3.946M	$30.07M	$4.375M
YoY Change	-68.78%	118.1%	101.52%
Gross Profit Margin	4.7%	14.99%	14.99%
Selling, General & Admin	$19.20M	$117.8M	$17.14M
YoY Change	-37.07%	143.58%	142.08%
% of Gross Profit	486.67%	391.83%	391.86%
Research & Development			16.00M cnies
YoY Change			13.48%
% of Gross Profit			365.71%
Depreciation & Amortization	$3.237M	$3.192M	4.600M cnies
YoY Change	24.4%	55.18%	39.39%
% of Gross Profit	82.03%	10.62%	105.14%
Operating Expenses	$18.67M	$117.3M	$16.61M
YoY Change	-23.06%	157.09%	118.33%
Operating Profit	-$14.72M	-$87.22M	-$12.23M
YoY Change	26.66%	173.97%	125.04%
Interest Expense	$2.964M	-$2.970M	$895.0K
YoY Change	-172.74%	-58.7%	16.54%
% of Operating Profit
Other Income/Expense, Net			4.533M cnies
YoY Change
Pretax Income	-$11.76M	-$90.19M	-$13.13M
YoY Change	-25.1%	129.06%	111.61%
Income Tax	-$85.00K	-$171.0K	-$25.00K
% Of Pretax Income
Net Earnings	-$10.49M	-$87.62M	-$12.75M
YoY Change	-26.49%	125.62%	108.42%
Net Earnings / Revenue	-12.49%	-43.69%	-43.69%
Basic Earnings Per Share			-$7.80
Diluted Earnings Per Share	-$0.77	-$7.80	-$7.80
COMMON SHARES
Basic Shares Outstanding	13.57M shares		11.23M shares
Diluted Shares Outstanding			11.23M shares

Balance Sheet

Concept	2023 Q3	2023 Q1	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$79.95M	$71.93M	$71.93M
YoY Change	7.34%	7.86%	7.86%
Cash & Equivalents	$79.95M	$10.54M	$71.93M
Short-Term Investments
Other Short-Term Assets	$75.90M	$34.50M	$65.33M
YoY Change	-10.04%	6899900.0%	58.87%
Inventory	$13.61M	$2.353M	$16.17M
Prepaid Expenses
Receivables	$40.84M	$7.612M	$52.31M
Other Receivables	$26.91M	$31.26M	$31.26M
Total Short-Term Assets	$237.2M	$34.49M	$237.0M
YoY Change	11.69%	13.49%	22.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$70.01M	$8.939M	$74.46M
YoY Change	-15.49%	48.29%	36.4%
Goodwill
YoY Change
Intangibles		$244.0K
YoY Change		-40.2%
Long-Term Investments			$0.00
YoY Change
Other Assets	$222.0K		$0.00
YoY Change	-57.79%		-100.0%
Total Long-Term Assets	$71.30M	$11.08M	$76.14M
YoY Change	-16.63%	21.85%	31.9%
TOTAL ASSETS
Total Short-Term Assets	$237.2M	$34.49M	$237.0M
Total Long-Term Assets	$71.30M	$11.08M	$76.14M
Total Assets	$308.5M	$45.57M	$313.1M
YoY Change	3.56%	15.42%	24.94%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$102.8M	$18.44M	$126.7M
YoY Change	-38.03%	57.04%	69.98%
Accrued Expenses	$18.61M	$22.88M	$22.88M
YoY Change	294.84%	51.85%	51.85%
Deferred Revenue
YoY Change
Short-Term Debt	$47.43M	$7.849M	$53.94M
YoY Change	7.64%	39.27%	50.74%
Long-Term Debt Due	$1.080M	$157.0K	$1.080M
YoY Change	0.0%	24.6%	35.0%
Total Short-Term Liabilities	$255.6M	$35.75M	$245.7M
YoY Change	16.53%	39.13%	50.59%
LONG-TERM LIABILITIES
Long-Term Debt	$6.330M	1.080M cnies	$6.870M
YoY Change	-14.57%	35.0%	-14.34%
Other Long-Term Liabilities	$17.34M	6.440M cnies	$19.57M
YoY Change	-5.61%	-55.74%	34.53%
Total Long-Term Liabilities	$23.67M	$3.892M	$26.44M
YoY Change	-8.19%	7.28%	17.17%
TOTAL LIABILITIES
Total Short-Term Liabilities	$255.6M	$35.75M	$245.7M
Total Long-Term Liabilities	$23.67M	$3.892M	$26.44M
Total Liabilities	$274.6M	$39.64M	$269.1M
YoY Change	12.8%	35.19%	44.92%
SHAREHOLDERS EQUITY
Retained Earnings		-$25.60M
YoY Change		-71.0%
Common Stock		$1.000K
YoY Change		-100.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$33.95M	$6.414M	$44.09M
YoY Change
Total Liabilities & Shareholders Equity	$308.5M	$45.57M	$313.1M
YoY Change	3.56%	15.42%	24.94%

Cashflow Statement

Concept	2023 Q3	2023 Q1	2023
OPERATING ACTIVITIES
Net Income	-$10.49M	-$87.62M	-$12.75M
YoY Change	-26.49%	125.62%	108.42%
Depreciation, Depletion And Amortization	$3.237M	$3.192M	4.600M cnies
YoY Change	24.4%	55.18%	39.39%
Cash From Operating Activities	-$13.08M	-$10.45M	-$2.203M
YoY Change	179.19%	713.39%	-32.96%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$696.0K	$377.0K
YoY Change	-100.0%	-10.19%	-59.15%
Acquisitions
YoY Change
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	$0.00	-$696.0K	-$422.0K
YoY Change	-100.0%	-186.67%	-54.08%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net			870.0K cnies
YoY Change
Cash From Financing Activities	19.58M	11.34M	$2.662M
YoY Change	181.61%	-4461.92%	-80.55%
NET CHANGE
Cash From Operating Activities	-13.08M	-10.45M	-$2.203M
Cash From Investing Activities	0.000	-696.0K	-$422.0K
Cash From Financing Activities	19.58M	11.34M	$2.662M
Net Change In Cash	6.500M	193.0K	$763.0K
YoY Change	10056.25%	-126.01%	-91.61%
FREE CASH FLOW
Cash From Operating Activities	-$13.08M	-$10.45M	-$2.203M
Capital Expenditures	$0.00	$696.0K	$377.0K
Free Cash Flow	-$13.08M	-$11.15M	-$2.580M
YoY Change	89.88%	441.17%	-38.7%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		cny
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		cny
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q1	us-gaap	Preferred Stock Value PreferredStockValue		cny
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		cny
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		cny
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		usd
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-40306
CY2023	dei	Entity Registrant Name EntityRegistrantName	UTime Limited
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	7th Floor
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Building 5A
CY2023	dei	Entity Address Address Line3 EntityAddressAddressLine3	Shenzhen Software Industry Base
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Nanshan District
CY2023	dei	Entity Address Country EntityAddressCountry	CN
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	518061
CY2023	dei	Security12b Title Security12bTitle	Ordinary shares, par value US$ $0.0001 per share
CY2023	dei	Trading Symbol TradingSymbol	UTME
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	13567793	shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Name AuditorName	Audit Alliance LLP
CY2023	dei	Auditor Location AuditorLocation	Singapore
CY2023	dei	Auditor Firm AuditorFirmId	3487
CY2022Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	66692000	cny
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	71934000	cny
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	10468000	usd
CY2022Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000	cny
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	500000	cny
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	73000	usd
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	22417000	cny
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	52308000	cny
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	7612000	usd
CY2022Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	65815000	cny
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	95508000	cny
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	13899000	usd
CY2022Q1	utme	Due From Related Partie DueFromRelatedPartie	1422000	cny
CY2023Q1	utme	Due From Related Partie DueFromRelatedPartie	584000	cny
CY2023Q1	utme	Due From Related Partie DueFromRelatedPartie	85000	usd
CY2022Q1	us-gaap	Inventory Net InventoryNet	36071000	cny
CY2023Q1	us-gaap	Inventory Net InventoryNet	16169000	cny
CY2023Q1	us-gaap	Inventory Net InventoryNet	2353000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	192917000	cny
CY2023Q1	us-gaap	Assets Current AssetsCurrent	237003000	cny
CY2023Q1	us-gaap	Assets Current AssetsCurrent	34490000	usd
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	38270000	cny
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	61429000	cny
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8939000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	16319000	cny
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	13030000	cny
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1896000	usd
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	2592000	cny
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1677000	cny
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	244000	usd
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	541000	cny
CY2022Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	57722000	cny
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	76136000	cny
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	11079000	usd
CY2022Q1	us-gaap	Assets Assets	250639000	cny
CY2023Q1	us-gaap	Assets Assets	313139000	cny
CY2023Q1	us-gaap	Assets Assets	45569000	usd
CY2022Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	74531000	cny
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	126691000	cny
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	18437000	usd
CY2022Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	35780000	cny
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	53935000	cny
CY2023Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	7849000	usd
CY2022Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	800000	cny
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1080000	cny
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	157000	usd
CY2022Q1	utme	Due To Related Partie Current DueToRelatedPartieCurrent	4499000	cny
CY2023Q1	utme	Due To Related Partie Current DueToRelatedPartieCurrent	5500000	cny
CY2023Q1	utme	Due To Related Partie Current DueToRelatedPartieCurrent	800000	usd
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3360000	cny
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3673000	cny
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	535000	usd
CY2022Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	44148000	cny
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	54772000	cny
CY2023Q1	us-gaap	Accrued Liabilities And Other Liabilities AccruedLiabilitiesAndOtherLiabilities	7971000	usd
CY2022Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	18000	cny
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	18000	cny
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	3000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	163136000	cny
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	245669000	cny
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	35752000	usd
CY2022Q1	us-gaap	Long Term Transition Bond LongTermTransitionBond	8020000	cny
CY2023Q1	us-gaap	Long Term Transition Bond LongTermTransitionBond	6870000	cny
CY2023Q1	us-gaap	Long Term Transition Bond LongTermTransitionBond	1000000	usd
CY2023Q1	utme	Government Grant GovernmentGrant	8697000	cny
CY2023Q1	utme	Government Grant GovernmentGrant	1266000	usd
CY2022Q1	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	466000	cny
CY2023Q1	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	295000	cny
CY2023Q1	us-gaap	Deferred Tax And Other Liabilities Noncurrent DeferredTaxAndOtherLiabilitiesNoncurrent	43000	usd
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	14549000	cny
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	10876000	cny
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	1583000	usd
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	23035000	cny
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	26738000	cny
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	3892000	usd
CY2022Q1	utme	Amounts Of Consolidated Vi Es Without Recourse AmountsOfConsolidatedVIEsWithoutRecourse	183639000	cny
CY2023Q1	utme	Amounts Of Consolidated Vi Es Without Recourse AmountsOfConsolidatedVIEsWithoutRecourse	265773000	cny
CY2022Q1	us-gaap	Liabilities Liabilities	186171000	cny
CY2023Q1	us-gaap	Liabilities Liabilities	272407000	cny
CY2023Q1	us-gaap	Liabilities Liabilities	39644000	usd
CY2022Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	140000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	140000000	shares
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	8267793	shares
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	8267793	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	13567793	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	13567793	shares
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	5000	cny
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	9000	cny
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	1000	usd
CY2022Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	152236000	cny
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	216504000	cny
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	31507000	usd
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-88277000	cny
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-175893000	cny
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-25597000	usd
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1024000	cny
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	3469000	cny
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	503000	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	64988000	cny
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	44089000	cny
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	6414000	usd
CY2022Q1	us-gaap	Minority Interest MinorityInterest	-520000	cny
CY2023Q1	us-gaap	Minority Interest MinorityInterest	-3357000	cny
CY2023Q1	us-gaap	Minority Interest MinorityInterest	-489000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	64468000	cny
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	40732000	cny
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5925000	usd
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	250639000	cny
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	313139000	cny
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	45569000	usd
CY2021	us-gaap	Revenues Revenues	246899000	cny
CY2022	us-gaap	Revenues Revenues	275508000	cny
CY2023	us-gaap	Revenues Revenues	200547000	cny
CY2023	us-gaap	Revenues Revenues	29184000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	228732000	cny
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	261723000	cny
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	170482000	cny
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	24809000	usd
CY2021	us-gaap	Gross Profit GrossProfit	18167000	cny
CY2022	us-gaap	Gross Profit GrossProfit	13785000	cny
CY2023	us-gaap	Gross Profit GrossProfit	30065000	cny
CY2023	us-gaap	Gross Profit GrossProfit	4375000	usd
CY2021	us-gaap	Selling Expense SellingExpense	4127000	cny
CY2022	us-gaap	Selling Expense SellingExpense	5459000	cny
CY2023	us-gaap	Selling Expense SellingExpense	7391000	cny
CY2023	us-gaap	Selling Expense SellingExpense	1076000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	25695000	cny
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	39499000	cny
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	110412000	cny
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	16068000	usd
CY2021	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2875000	cny
CY2022	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-3328000	cny
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	3694000	cny
CY2023	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	538000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	32697000	cny
CY2022	us-gaap	Operating Expenses OperatingExpenses	48286000	cny
CY2023	us-gaap	Operating Expenses OperatingExpenses	114109000	cny
CY2023	us-gaap	Operating Expenses OperatingExpenses	16606000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-14530000	cny
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-34501000	cny
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-84044000	cny
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-12231000	usd
CY2021	us-gaap	Interest Expense InterestExpense	2461000	cny
CY2022	us-gaap	Interest Expense InterestExpense	4875000	cny
CY2023	us-gaap	Interest Expense InterestExpense	6149000	cny
CY2023	us-gaap	Interest Expense InterestExpense	895000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-16991000	cny
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-39376000	cny
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-90193000	cny
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-13126000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-364000	cny
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-46000	cny
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-171000	cny
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-25000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-16627000	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-39330000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-90022000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-13101000	usd
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-497000	cny
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	2406000	cny
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	350000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-16627000	cny
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-38833000	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-87616000	cny
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-12751000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-16627000	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-39330000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-90022000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-13101000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-1868000	cny
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	377000	cny
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-2445000	cny
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax	-356000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-14759000	cny
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-39707000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-87577000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-12745000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-497000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	2406000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	350000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-14759000	cny
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-39210000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-85171000	cny
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-12395000	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.68
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.76
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.8
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.14
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4517793	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8164771	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11229985	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11229985	shares
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	39937000	cny
CY2021	us-gaap	Profit Loss ProfitLoss	-16627000	cny
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	1868000	cny
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	25178000	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-39330000	cny
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	79030000	cny
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-410000	cny
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	64468000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-90022000	cny
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	64272000	cny
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	2014000	cny
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	40732000	cny
CY2021	us-gaap	Profit Loss ProfitLoss	-16627000	cny
CY2022	us-gaap	Profit Loss ProfitLoss	-39330000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-90022000	cny
CY2023	us-gaap	Profit Loss ProfitLoss	-13101000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3954000	cny
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4333000	cny
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	5794000	cny
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	843000	usd
CY2021	us-gaap	Inventory Write Down InventoryWriteDown	7589000	cny
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	293000	cny
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	-407000	cny
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	-59000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-836000	cny
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	3406000	cny
CY2021	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	-833000	cny
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	63656000	cny
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	9264000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-10000	cny
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-184000	cny
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-27000	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	348000	cny
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-171000	cny
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-25000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-21477000	cny
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5725000	cny
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	27564000	cny
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4011000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	26173000	cny
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-5937000	cny
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	25871000	cny
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	3765000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10934000	cny
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4629000	cny
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-20627000	cny
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3002000	usd
CY2021	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-9924000	cny
CY2022	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	27324000	cny
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	19629000	cny
CY2023	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2856000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	27993000	cny
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-11925000	cny
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	8888000	cny
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	1293000	usd
CY2021	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	527000	cny
CY2022	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	-699000	cny
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	881000	cny
CY2023	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	128000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-400000	cny
CY2023	utme	Increase Decrease In Government Grants IncreaseDecreaseInGovernmentGrants	8697000	cny
CY2023	utme	Increase Decrease In Government Grants IncreaseDecreaseInGovernmentGrants	1266000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	208000	cny
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-541000	cny
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-79000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2521000	cny
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-20865000	cny
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-15138000	cny
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2203000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5858000	cny
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2593000	cny
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	377000	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	2201000	cny
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	307000	cny
CY2023	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	45000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-28000	cny
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2201000	cny
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5830000	cny
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2900000	cny
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-422000	usd
CY2021	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	47600000	cny
CY2022	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	46500000	cny
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	66300000	cny
CY2023	us-gaap	Proceeds From Short Term Debt ProceedsFromShortTermDebt	9648000	usd
CY2021	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	900000	cny
CY2022	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	5980000	cny
CY2023	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	4010000	cny
CY2023	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	584000	usd
CY2022	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	9000000	cny
CY2021	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	1500000	cny
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	3000000	cny
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	3000000	cny
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	437000	usd
CY2021	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	31800000	cny
CY2022	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	41520000	cny
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	48145000	cny
CY2023	us-gaap	Repayments Of Short Term Debt RepaymentsOfShortTermDebt	7006000	usd
CY2021	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	1200000	cny
CY2022	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	5760000	cny
CY2023	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	870000	cny
CY2023	us-gaap	Repayments Of Other Long Term Debt RepaymentsOfOtherLongTermDebt	127000	usd
CY2022	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	19003000	cny
CY2022	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates	6429000	cny
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	88262000	cny
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	14000000	cny
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	86888000	cny
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	18295000	cny
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2662000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-855000	cny
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-2478000	cny
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4985000	cny
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	725000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8423000	cny
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	57715000	cny
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	5242000	cny
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	763000	usd
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1054000	cny
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9477000	cny
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67192000	cny
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9778000	usd
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9477000	cny
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	67192000	cny
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72434000	cny
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10541000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	364000	cny
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2461000	cny
CY2022	us-gaap	Interest Paid Net InterestPaidNet	4707000	cny
CY2023	us-gaap	Interest Paid Net InterestPaidNet	6097000	cny
CY2023	us-gaap	Interest Paid Net InterestPaidNet	887000	usd
CY2021	utme	Reconciliation Restricted Cash ReconciliationRestrictedCash	500000	cny
CY2022	utme	Reconciliation Restricted Cash ReconciliationRestrictedCash	500000	cny
CY2023	utme	Reconciliation Restricted Cash ReconciliationRestrictedCash	500000	cny
CY2023	utme	Reconciliation Restricted Cash ReconciliationRestrictedCash	73000	usd
CY2021	utme	Reconciliation Cash And Cash Equivalents ReconciliationCashAndCashEquivalents	8977000	cny
CY2022	utme	Reconciliation Cash And Cash Equivalents ReconciliationCashAndCashEquivalents	66692000	cny
CY2023	utme	Reconciliation Cash And Cash Equivalents ReconciliationCashAndCashEquivalents	71934000	cny
CY2023	utme	Reconciliation Cash And Cash Equivalents ReconciliationCashAndCashEquivalents	10468000	usd
CY2021	utme	Reconciliation Cash Cash Equivalents And Restricted Cash ReconciliationCashCashEquivalentsAndRestrictedCash	9477000	cny
CY2022	utme	Reconciliation Cash Cash Equivalents And Restricted Cash ReconciliationCashCashEquivalentsAndRestrictedCash	67192000	cny
CY2023	utme	Reconciliation Cash Cash Equivalents And Restricted Cash ReconciliationCashCashEquivalentsAndRestrictedCash	72434000	cny
CY2023	utme	Reconciliation Cash Cash Equivalents And Restricted Cash ReconciliationCashCashEquivalentsAndRestrictedCash	10541000	usd
CY2018Q1	us-gaap	Asset Acquisition Consideration Transferred AssetAcquisitionConsiderationTransferred	9600000	usd
CY2023	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	17200000	cny
CY2023	utme	Other Comprehensive Income OtherComprehensiveIncome	1000000	cny
CY2023Q1	us-gaap	Other Additional Capital OtherAdditionalCapital	16200000	cny
CY2018Q1	us-gaap	Shares Issued SharesIssued	100000	shares
CY2019Q1	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	1	shares
CY2019Q2	us-gaap	Business Combination Control Obtained Description BusinessCombinationControlObtainedDescription	On April 4, 2019, Bridgetime approved a board resolution that forfeited 15,000 shares held by Mr. Yunchuan Li, cancelled those shares accordingly and amended Bridgetime’s memorandum of association that changed authorized shares from 150,000 to 135,000 at a par value of US$1.00 which was accounted as a cancellation of non-controlling interest in the consolidated statements of shareholders’ equity.After this, Mr. WuKai Song owned 100% of equity interest of Bridgetime, which are controlled by Mr. Bao through an entrust agreement between Mr. Bao and Mr. Wukai Song. On May 23, 2019, Bridgetime approved a board resolution that transferred 135,000 ordinary shares owning by Mr. Wukai Song to UTime Limited. Since inception, Bridgetime has only made nominal investments into Do Mobile and no substantial business operations have occurred.
CY2019Q2	us-gaap	Stock Issued During Period Shares Share Based Compensation StockIssuedDuringPeriodSharesShareBasedCompensation	15000	shares
CY2020Q2	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	7620000	shares
CY2020Q2	utme	Ordinary Shares OrdinaryShares	239721	shares
CY2021Q2	utme	Ordinary Shares Repurchased Description OrdinarySharesRepurchasedDescription	Before and after the repurchase of ordinary shares, Mr. Bao, through Grandsky Phoenix Limited, and Mr. He, through HMercury Capital Limited, own 96.95% and 3.05% of our issued and outstanding ordinary shares, respectively. The Company considers this repurchase of ordinary shares was part of the Company’s recapitalization to result in 4,517,793 ordinary shares issued and outstanding prior to completion of its IPO. The Company believes it is appropriate to reflect these nominal share repurchases to result in 4,517,793 ordinary shares being issued and outstanding or reduction of 63.5% of total ordinary shares being issued and outstanding after the repurchase of ordinary shares similar to 0.365-for-1 reverse stock split.
CY2022	us-gaap	Management And Service Fees Rate ManagementAndServiceFeesRate	1	pure
CY2019Q3	utme	Equity Interests Percentage EquityInterestsPercentage	1	pure
CY2021	utme	Revenue Revenue	240742000	cny
CY2022	utme	Revenue Revenue	273979000	cny
CY2023	utme	Revenue Revenue	200450000	cny
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10722000	cny
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-29643000	cny
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19221000	cny
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3020000	cny
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-19806000	cny
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-15269000	cny
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2201000	cny
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-5830000	cny
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2900000	cny
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	14000000	cny
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	17629000	cny
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	18295000	cny
CY2021Q4	utme	Equity Interest Rate EquityInterestRate	0.51	pure
CY2022Q1	utme	Equity Interest Rate EquityInterestRate	0.85	pure
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	237000000	cny
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	34500000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	245700000	cny
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	35800000	usd
CY2023Q1	utme	Working Capital Deficit WorkingCapitalDeficit	8700000	cny
CY2023Q1	utme	Working Capital Deficit WorkingCapitalDeficit	1300000	usd
CY2022Q1	us-gaap	Other Assets Current OtherAssetsCurrent	192900000	cny
CY2022Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	163100000	cny
CY2022Q1	utme	Working Capital Deficit WorkingCapitalDeficit	29800000	cny
CY2023Q1	utme	Incurred Net Loss IncurredNetLoss	87600000	cny
CY2023Q1	utme	Incurred Net Loss IncurredNetLoss	12700000	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration:underline">Use of estimates</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The preparation of the consolidated financial statements in conformity with US GAAP requires management of the Company to make a number of estimates and assumptions relating to the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the period. Management evaluates these estimates and assumptions on a regular basis. Significant accounting estimates reflected in the Company’s consolidated financial statements include but are not limited to estimates and judgments applied in the allowance for receivables, write down of other assets, estimated useful lives of property and equipment, impairment on inventory, sales return, product warranties, the valuation allowance for deferred tax assets and income tax and provision for employee benefits. Actual results could differ from those estimates and judgments.</p>
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><i><span style="text-decoration:underline">Concentration of credit risk and major customers</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Assets that potentially subject the Company to significant concentration of credit risk primarily consist of cash and cash equivalents, restricted cash, accounts receivable and other current assets. The maximum exposure of such assets to credit risk is their carrying amounts as at the balance sheet dates. As of March 31, 2022 and 2023, the aggregate amounts of cash and cash equivalents, and restricted cash are RMB67.2 million and RMB72.4 million respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 36pt">To limit exposure to credit risk relating to deposits, the Company primarily place cash deposits with large financial institutions in PRC. The Company conducts credit evaluations of its customers, and generally does not require collateral or other security from them. The Company establishes an accounting policy for allowance for doubtful accounts on the individual customer’s financial condition, credit history, and the current economic conditions. As of March 31, 2022 and 2023, the Company recorded RMB0.1 million of allowances for accounts receivable.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Major customers and accounts receivable — <span>During the year ended March 31, 2021, the Company had two customers that accounted over 10% of revenues, and revenue from these customers amounted to RMB102.1 million and RMB44.7 million, respectively, relate to Original Equipment Manufacturer (“OEM”)/Original Design Manufacturer (“ODM”) services segment and sales of face mask. </span>During the year ended March 31, 2022, the Company had two customers that accounted over 10% of revenues, and revenue from the customers amounted to RMB116.4 million and RMB54.6 million, respectively, relate to OEM/ ODM services segment. The Company had three customers that accounted over 10% of total accounts receivable at March 31, 2022, amounting to RMB8.3 million, RMB6.3 million and RMB4.3 million, respectively. During the year ended March 31, 2023, the Company had three customers that accounted over 10% of revenues, and revenue from the customers amounted to RMB44.4 million, RMB25.9 million and RMB25.8 million, respectively, relate to OEM/ ODM services segment. The Company had four customers that accounted over 10% of total accounts receivable at March 31, 2023, amounting to RMB14.0 million, RMB11.9 million, RMB9.4 million and RMB8.6 million, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Major suppliers — <span>During the year ended March 31, 2021, the Company had no supplier accounted over 10% of total purchases and processing fees.</span> During the year ended March 31, 2022, the Company had one supplier accounted over 10% of total purchases and processing fees from the supplier amounted to RMB39.5 million. During the year ended March 31, 2023, the Company had no supplier accounted over 10% of total purchases.</p>
CY2022Q1	us-gaap	Restricted Cash RestrictedCash	67200000	cny
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	72400000	cny
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	100000	cny
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	100000	cny
CY2022	utme	Revenue Percentage RevenuePercentage	0.10	pure
CY2021	utme	Purchase Percentage PurchasePercentage	0.10	pure
CY2023	utme	Office Real Estate OfficeRealEstate	P48Y
CY2023Q1	us-gaap	Deferred Revenue And Credits DeferredRevenueAndCredits	8700000	cny
CY2021	us-gaap	Other Income OtherIncome	1300000	cny
CY2022	us-gaap	Other Income OtherIncome	2900000	cny
CY2023	us-gaap	Other Income OtherIncome	600000	cny
CY2021	utme	Revenues Oemodm RevenuesOEMODM	-195995000	cny
CY2022	utme	Revenues Oemodm RevenuesOEMODM	-273979000	cny
CY2023	utme	Revenues Oemodm RevenuesOEMODM	-200450000	cny
CY2021	utme	Inhouse Brand InhouseBrand	6157000	cny
CY2022	utme	Inhouse Brand InhouseBrand	1529000	cny
CY2023	utme	Inhouse Brand InhouseBrand	98000	cny
CY2021	utme	Fack Mask FackMask	44747000	cny
CY2021	utme	Total Net Sale TotalNetSale	246899000	cny
CY2022	utme	Total Net Sale TotalNetSale	275508000	cny
CY2023	utme	Total Net Sale TotalNetSale	200548000	cny
CY2023	utme	Value Added Tax Percentage ValueAddedTaxPercentage	In the PRC, value added tax (the “VAT”) of 17% (before May 1, 2018), 16% (from May 1, 2018 to April 1, 2019) and 13% (after April 1, 2019 until now) on invoice amount is collected in respect of the sales of goods on behalf of tax authorities. The Company reports revenue net of VAT. VIE and its subsidiary in China that are VAT general tax payers are allowed to offset qualified VAT paid against their output VAT liabilities.
CY2021	us-gaap	Advertising Expense AdvertisingExpense	100000	cny
CY2022	us-gaap	Advertising Expense AdvertisingExpense	100000	usd
CY2021	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1200000	cny
CY2022	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1400000	cny
CY2023	us-gaap	Other Cost Of Operating Revenue OtherCostOfOperatingRevenue	1600000	cny
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	7200000	cny
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14100000	cny
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	16000000	cny
CY2021	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	400000	cny
CY2022	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1100000	cny
CY2023	us-gaap	Benefits Losses And Expenses BenefitsLossesAndExpenses	1300000	cny
CY2023	utme	Registered Capital Percentage RegisteredCapitalPercentage	0.50	pure
CY2023	utme	Reserves And Surplus ReservesAndSurplus	0.10	pure
CY2021Q1	utme	Statutory Reserve Funds StatutoryReserveFunds	200000	cny
CY2021	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-16627000	cny
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-38833000	cny
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Basic NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic	-87616000	cny
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4517793	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	8164771	shares
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11229985	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.68
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.76
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-7.8
CY2023	us-gaap	Revenue Recognition Customer Acquisitions RevenueRecognitionCustomerAcquisitions	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i><span style="text-decoration:underline">Acquisitions</span></i></p><p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0; text-indent: 36pt">The Company accounts for acquisitions of an asset or group of similar identifiable assets that do not meet the definition of a business as an asset acquisition using the cost accumulated method, whereby the cost of the acquisition, including certain transaction costs, is allocated to the assets acquired on the basis of their relative fair values. No goodwill is recognized in an asset acquisition. Intangible assets acquired in an asset acquisition for use in research and development activities which have no alternative future use are expensed as in-process research and development on the acquisition date. Intangible assets acquired for use in research and development activities which have an alternative future use are capitalized as in-process research and development. Future costs to develop these assets are recorded to research and development expense as they are incurred.</p>
CY2022Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	22543000	cny
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	52444000	cny
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	126000	cny
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	136000	cny
CY2022Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	22417000	cny
CY2023Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	52308000	cny
CY2020Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	838000	cny
CY2021Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	878000	cny
CY2022Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	126000	cny
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	50000	cny
CY2022	utme	Allowance For Doubtful Other Receivables Reversal AllowanceForDoubtfulOtherReceivablesReversal	748000	cny
CY2021	utme	Foreign Currency Translation Difference ForeignCurrencyTranslationDifference	-10000	cny
CY2022	utme	Foreign Currency Translation Difference ForeignCurrencyTranslationDifference	-4000	cny
CY2023	utme	Foreign Currency Translation Difference ForeignCurrencyTranslationDifference	10000	cny
CY2021Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	878000	cny
CY2022Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	126000	cny
CY2023Q1	us-gaap	Allowance For Doubtful Other Receivables Current AllowanceForDoubtfulOtherReceivablesCurrent	136000	cny
CY2022Q1	utme	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	100000	cny
CY2023Q1	utme	Allowance For Doubtful Account Receivable AllowanceForDoubtfulAccountReceivable	100000	cny
CY2022Q1	us-gaap	Supplies Supplies	40620000	cny
CY2023Q1	us-gaap	Supplies Supplies	64827000	cny
CY2022Q1	us-gaap	Prepaid Taxes PrepaidTaxes	568000	cny
CY2023Q1	us-gaap	Prepaid Taxes PrepaidTaxes	412000	cny
CY2022Q1	utme	Receivables From Supply Chain Service Providers ReceivablesFromSupplyChainServiceProviders	4829000	cny
CY2023Q1	utme	Receivables From Supply Chain Service Providers ReceivablesFromSupplyChainServiceProviders	7648000	cny
CY2022Q1	utme	Prepaid Expenses Expected Return Assets PrepaidExpensesExpectedReturnAssets	1000	cny
CY2023Q1	utme	Prepaid Expenses Expected Return Assets PrepaidExpensesExpectedReturnAssets	1000	cny
CY2022Q1	utme	Prepaid Expenses Other Receivables PrepaidExpensesOtherReceivables	21460000	cny
CY2023Q1	utme	Prepaid Expenses Other Receivables PrepaidExpensesOtherReceivables	24282000	cny
CY2022Q1	utme	Prepaid Expenses Allowance For Doubtful Accounts PrepaidExpensesAllowanceForDoubtfulAccounts	-1663000	cny
CY2023Q1	utme	Prepaid Expenses Allowance For Doubtful Accounts PrepaidExpensesAllowanceForDoubtfulAccounts	-1662000	cny
CY2022Q1	utme	Prepaid Expenses And Others Current Assets Net PrepaidExpensesAndOthersCurrentAssetsNet	65815000	cny
CY2023Q1	utme	Prepaid Expenses And Others Current Assets Net PrepaidExpensesAndOthersCurrentAssetsNet	95508000	cny
CY2022	utme	Expire Date ExpireDate	2022-03-31
CY2022Q1	us-gaap	Other Receivables OtherReceivables	5000000	cny
CY2023Q1	us-gaap	Other Receivables OtherReceivables	2000000	cny
CY2020Q1	utme	Allowance For Doubtful Accounts Receivables AllowanceForDoubtfulAccountsReceivables	4006000	cny
CY2021Q1	utme	Allowance For Doubtful Accounts Receivables AllowanceForDoubtfulAccountsReceivables	674000	cny
CY2022Q1	utme	Allowance For Doubtful Accounts Receivables AllowanceForDoubtfulAccountsReceivables	1663000	cny
CY2021	utme	Reversal Additions Debt For The Year ReversalAdditionsDebtForTheYear	-886000	cny
CY2022	utme	Reversal Additions Debt For The Year ReversalAdditionsDebtForTheYear	3406000	cny
CY2021	utme	Debt Written Off For The Year DebtWrittenOffForTheYear	2446000	cny
CY2022	utme	Debt Written Off For The Year DebtWrittenOffForTheYear	2359000	cny
CY2022	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	-58000	cny
CY2023	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss	-1000	cny
CY2021Q1	utme	Allowance For Doubtful Accounts Receivables AllowanceForDoubtfulAccountsReceivables	674000	cny
CY2022Q1	utme	Allowance For Doubtful Accounts Receivables AllowanceForDoubtfulAccountsReceivables	1663000	cny
CY2023Q1	utme	Allowance For Doubtful Accounts Receivables AllowanceForDoubtfulAccountsReceivables	1662000	cny
CY2023Q1	utme	Allowance For Doubtful Accounts On Advance To Suppliers AllowanceForDoubtfulAccountsOnAdvanceToSuppliers	1700000	cny
CY2022Q1	utme	Allowance For Doubtful Accounts On Advance To Suppliers AllowanceForDoubtfulAccountsOnAdvanceToSuppliers	1700000	cny
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	32004000	cny
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	12294000	cny
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1326000	cny
CY2023Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	2972000	cny
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	13533000	cny
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	11217000	cny
CY2022Q1	us-gaap	Inventory Gross InventoryGross	46863000	cny
CY2023Q1	us-gaap	Inventory Gross InventoryGross	26483000	cny
CY2022Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	10792000	cny
CY2023Q1	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	10314000	cny
CY2022	utme	Total Inventory TotalInventory	36071000	cny
CY2023	utme	Total Inventory TotalInventory	16169000	cny
CY2020Q1	utme	Inventory Reserve InventoryReserve	5962000	cny
CY2021Q1	utme	Inventory Reserve InventoryReserve	13393000	cny
CY2022Q1	utme	Inventory Reserve InventoryReserve	10792000	cny
CY2021Q1	utme	Inventory Reserve Additional Charges InventoryReserveAdditionalCharges	7589000	cny
CY2022Q1	utme	Inventory Reserve Additional Charges InventoryReserveAdditionalCharges	-2467000	cny
CY2023Q1	utme	Inventory Reserve Additional Charges InventoryReserveAdditionalCharges	407000	cny
CY2021	utme	Inventory Reserve Foreign Currency Translation Difference InventoryReserveForeignCurrencyTranslationDifference	-158000	cny
CY2022	utme	Inventory Reserve Foreign Currency Translation Difference InventoryReserveForeignCurrencyTranslationDifference	-134000	cny
CY2023	utme	Inventory Reserve Foreign Currency Translation Difference InventoryReserveForeignCurrencyTranslationDifference	-885000	cny
CY2021Q1	utme	Inventory Reserve InventoryReserve	13393000	cny
CY2022Q1	utme	Inventory Reserve InventoryReserve	10792000	cny
CY2023Q1	utme	Inventory Reserve InventoryReserve	10314000	cny
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	55808000	cny
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	82278000	cny
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	17538000	cny
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	20849000	cny
CY2022Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	38270000	cny
CY2023Q1	us-gaap	Property Plant And Equipment Other Net PropertyPlantAndEquipmentOtherNet	61429000	cny
CY2022	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	40000.00	cny
CY2023	us-gaap	Proceeds From Sale Of Other Property Plant And Equipment ProceedsFromSaleOfOtherPropertyPlantAndEquipment	20000.00	cny
CY2021	us-gaap	Depreciation Depreciation	3200000	usd
CY2022	us-gaap	Depreciation Depreciation	3300000	cny
CY2023	us-gaap	Depreciation Depreciation	4600000	cny
CY2022Q1	us-gaap	Sale Leaseback Transaction Historical Cost SaleLeasebackTransactionHistoricalCost	29578000	cny
CY2023Q1	us-gaap	Sale Leaseback Transaction Historical Cost SaleLeasebackTransactionHistoricalCost	29578000	cny
CY2022Q1	us-gaap	Sale Leaseback Transaction Accumulated Depreciation SaleLeasebackTransactionAccumulatedDepreciation	9436000	cny
CY2023Q1	us-gaap	Sale Leaseback Transaction Accumulated Depreciation SaleLeasebackTransactionAccumulatedDepreciation	12094000	cny
CY2022Q1	us-gaap	Sale Leaseback Transaction Net Book Value SaleLeasebackTransactionNetBookValue	20142000	cny
CY2023Q1	us-gaap	Sale Leaseback Transaction Net Book Value SaleLeasebackTransactionNetBookValue	17484000	cny
CY2023	utme	Schedule Of Future Minimum Rental Payments For Operating Leases Table Text Blockj ScheduleOfFutureMinimumRentalPaymentsForOperatingLeasesTableTextBlockj	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: justify">Year ending March 31,</td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">RMB</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 88%; text-align: justify">2024</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">804</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: justify; padding-bottom: 1.5pt">2025</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">201</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: justify; padding-bottom: 4pt">Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">1,005</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table>
CY2023Q1	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within One Year FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinOneYear	804000	cny
CY2023Q1	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions Within Two Years FutureMinimumSubleaseRentalsSaleLeasebackTransactionsWithinTwoYears	201000	cny
CY2023Q1	us-gaap	Future Minimum Sublease Rentals Sale Leaseback Transactions FutureMinimumSubleaseRentalsSaleLeasebackTransactions	1005000	cny
CY2021	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	2400000	cny
CY2022	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	2900000	cny
CY2023	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	3100000	cny
CY2021	utme	Depreciation Charges DepreciationCharges	2300000	cny
CY2023	utme	Depreciation Charges DepreciationCharges	2900000	cny
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1016000	cny
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	2265000	cny
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	3289000	cny
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	1163000	cny
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	973000	cny
CY2021	us-gaap	Lease Cost LeaseCost	2179000	cny
CY2022	us-gaap	Lease Cost LeaseCost	3238000	cny
CY2023	us-gaap	Lease Cost LeaseCost	3289000	cny
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1325000	cny
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1249000	cny
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	4514000	cny
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	4575000	cny
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	666000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	4575000	cny
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	666000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	7356000	cny
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	1071000	usd
CY2023Q1	utme	Lessee Operating Lease Liability Payments Due Total LesseeOperatingLeaseLiabilityPaymentsDueTotal	16506000	cny
CY2023Q1	utme	Lessee Operating Lease Liability Payments Due Total LesseeOperatingLeaseLiabilityPaymentsDueTotal	2403000	usd
CY2023Q1	utme	Operating Less Interest OperatingLessInterest	1957000	cny
CY2023Q1	utme	Operating Less Interest OperatingLessInterest	285000	usd
CY2023Q1	us-gaap	Present Value Of Future Minimum Lease Payments Sale Leaseback Transactions PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions	14549000	cny
CY2023Q1	us-gaap	Present Value Of Future Minimum Lease Payments Sale Leaseback Transactions PresentValueOfFutureMinimumLeasePaymentsSaleLeasebackTransactions	2118000	usd
CY2023Q1	utme	Longterm Lease Liabilities Record In Noncurrent Liabilities LongtermLeaseLiabilitiesRecordInNoncurrentLiabilities	-3673000	cny
CY2023Q1	utme	Longterm Lease Liabilities Record In Noncurrent Liabilities LongtermLeaseLiabilitiesRecordInNoncurrentLiabilities	-535000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	10876000	cny
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1583000	usd
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y6M21D
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y7M9D
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0703	pure
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.07	pure
CY2018Q1	us-gaap	Equity Method Investment Aggregate Cost EquityMethodInvestmentAggregateCost	1400000	cny
CY2018Q1	utme	Percentage Of Equity Interest PercentageOfEquityInterest	0.35	pure
CY2021	us-gaap	Equity Method Investment Other Than Temporary Impairment EquityMethodInvestmentOtherThanTemporaryImpairment	800000	cny
CY2022Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	1425000	cny
CY2023Q1	us-gaap	Deferred Finance Costs Gross DeferredFinanceCostsGross	1425000	cny
CY2022Q1	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	1425000	cny
CY2023Q1	us-gaap	Accumulated Amortization Of Other Deferred Costs AccumulatedAmortizationOfOtherDeferredCosts	1425000	cny
CY2022	utme	Prepayment For Property And Equipment And Intangible Asset PrepaymentForPropertyAndEquipmentAndIntangibleAsset	541000	cny
CY2022Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	541000	cny
CY2022Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	35780000	cny
CY2023Q1	us-gaap	Short Term Bank Loans And Notes Payable ShortTermBankLoansAndNotesPayable	53935000	cny
CY2022Q1	utme	Longterm Borrowings LongtermBorrowings	8820000	cny
CY2023Q1	utme	Longterm Borrowings LongtermBorrowings	7950000	cny
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	800000	cny
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1080000	cny
CY2022Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	8020000	cny
CY2023Q1	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	6870000	cny
CY2021Q4	utme	Working Capitals WorkingCapitals	22000000	cny
CY2021Q4	us-gaap	Debt Instrument Interest Rate Basis For Effective Rate DebtInstrumentInterestRateBasisForEffectiveRate	5.5%
CY2023	us-gaap	Line Of Credit Facility Periodic Payment LineOfCreditFacilityPeriodicPayment	1000000	cny
CY2022Q4	us-gaap	Debt Instrument Interest Rate Basis For Effective Rate DebtInstrumentInterestRateBasisForEffectiveRate	3.75%
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	6440000	cny
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5530000	cny
CY2023Q1	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1820000	cny
CY2022Q1	us-gaap	Notes And Loans Payable Current NotesAndLoansPayableCurrent	1.58	cny
CY2022Q1	us-gaap	Receivables From Customers ReceivablesFromCustomers	16607000	cny
CY2023Q1	us-gaap	Receivables From Customers ReceivablesFromCustomers	17087000	cny
CY2022Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	10220000	cny
CY2023Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	11910000	cny
CY2022Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	1484000	cny
CY2023Q1	us-gaap	Accrual For Taxes Other Than Income Taxes Current AccrualForTaxesOtherThanIncomeTaxesCurrent	7292000	cny
CY2022Q1	utme	Refund Liabilities RefundLiabilities	1000	cny
CY2023Q1	utme	Refund Liabilities RefundLiabilities	1000	cny
CY2022Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	50000	cny
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	50000	cny
CY2022Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	15786000	cny
CY2023Q1	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	18432000	cny
CY2022Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	44148000	cny
CY2023Q1	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	54772000	cny
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	3703000	cny
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	2316000	cny
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3179000	cny
CY2021	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	836000	cny
CY2022	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses	-3406000	cny
CY2022	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill	348000	cny
CY2021	us-gaap	Income Tax Expense Benefit Continuing Operations Government Grants IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants	-1289000	cny
CY2022	us-gaap	Income Tax Expense Benefit Continuing Operations Government Grants IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants	-2851000	cny
CY2023	us-gaap	Income Tax Expense Benefit Continuing Operations Government Grants IncomeTaxExpenseBenefitContinuingOperationsGovernmentGrants	-594000	cny
CY2021	utme	Loss On Equity Method Investments LossOnEquityMethodInvestments	-833000	cny
CY2021	utme	Others Others	-464000	cny
CY2022	utme	Others Others	-109000	cny
CY2023	utme	Others Others	-79000	cny
CY2021	utme	Other Income Expense Total OtherIncomeExpenseTotal	2875000	cny
CY2022	utme	Other Income Expense Total OtherIncomeExpenseTotal	3328000	cny
CY2023	utme	Other Income Expense Total OtherIncomeExpenseTotal	-3694000	cny
CY2021	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	17000000	cny
CY2022	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	39400000	cny
CY2023	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	90200000	cny
CY2023	utme	Enterprise Income Tax Description EnterpriseIncomeTaxDescription	The subsidiary, VIE and subsidiary of VIE in the PRC are subject to a uniform income tax rate of 25% for the years presented. UTime SZ is regarded as a Certified High and New Technology Enterprise (“HNTE”) and entitled to a favorable statutory tax rate of 15%. Preferential tax treatment of UTime SZ as HNTE from November 2, 2015 to December 23, 2024 has been granted by the relevant tax authorities. UTime SZ is entitled to a preferential tax rate of 15% which is subject to review by State Taxation Administration every three years. As a result of these preferential tax treatments, the reduced tax rates applicable to UTime SZ for the years ended March 31, 2021, 2022 and 2023 are 15%. However, UTime SZ has not enjoyed the above-mentioned preferential tax treatments for the years ended March 31, 2021, 2022 and 2023 due to its loss position and as such there is no impact of these tax holidays on net loss per share.
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Deductions EffectiveIncomeTaxRateReconciliationDeductions	0.50	pure
CY2023	utme	Addition Tax Deduction Description AdditionTaxDeductionDescription	The additional tax deduction has been increased from 50% of the qualified research and development expenses to 75%, effective from January 1, 2018 according to a tax incentives policy promulgated by the State Tax Bureau of the PRC in September 2018 (“Super Deduction”).
CY2023	utme	Additional Tax Deduction Rate AdditionalTaxDeductionRate	0.75	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Research And Development EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment	1	pure
CY2022Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	466000	cny
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	295000	cny
CY2022Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	116200000	cny
CY2023	utme	Withholding Tax Rate WithholdingTaxRate	0.10	pure
CY2023Q1	utme	Equity Interests Percentage EquityInterestsPercentage	0.25	pure
CY2023	utme	Subject Of Withholding Tax Rate SubjectOfWithholdingTaxRate	0.10	pure
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	364000	cny
CY2022	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	46000	cny
CY2023	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit	171000	cny
CY2021	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	364000	cny
CY2022	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	46000	cny
CY2023	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	171000	cny
CY2022Q1	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	2590000	cny
CY2023Q1	us-gaap	Other Long Term Debt Current OtherLongTermDebtCurrent	450000	cny
CY2022Q1	us-gaap	Inventory Adjustments InventoryAdjustments	3358000	cny
CY2023Q1	us-gaap	Inventory Adjustments InventoryAdjustments	1889000	cny
CY2022Q1	us-gaap	Deferred Revenue DeferredRevenue	977000	cny
CY2023Q1	us-gaap	Deferred Revenue DeferredRevenue	2174000	cny
CY2022Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1411000	cny
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3258000	cny
CY2022Q1	us-gaap	Other Long Term Investments OtherLongTermInvestments	1075000	cny
CY2022Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	21678000	cny
CY2023Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27977000	cny
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	31089000	cny
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	35748000	cny
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	27747000	cny
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	32490000	cny
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3342000	cny
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	3258000	cny
CY2022Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	1299000	cny
CY2023Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	3258000	cny
CY2022Q1	utme	Unrealized Foreign Exchange Difference And Others UnrealizedForeignExchangeDifferenceAndOthers	-2217000	cny
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	292000	cny
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	295000	cny
CY2022Q1	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	83200000	cny
CY2022Q1	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	33900000	cny
CY2023Q1	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	152	cny
CY2023Q1	us-gaap	Operating Loss Carryforwards Valuation Allowance OperatingLossCarryforwardsValuationAllowance	109.8	cny
CY2023Q1	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	42.2	cny
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.25	pure
CY2021	utme	Effect Of Preferential Tax Treatmentpercentage EffectOfPreferentialTaxTreatmentpercentage	-0.02	pure
CY2022	utme	Effect Of Preferential Tax Treatmentpercentage EffectOfPreferentialTaxTreatmentpercentage	-0.04	pure
CY2023	utme	Effect Of Preferential Tax Treatmentpercentage EffectOfPreferentialTaxTreatmentpercentage	-0.01	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.06	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.04	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.19	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.01	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate	-0.02	pure
CY2021	utme	Research And Development Superdeduction Percentage ResearchAndDevelopmentSuperdeductionPercentage	0.05	pure
CY2022	utme	Research And Development Superdeduction Percentage ResearchAndDevelopmentSuperdeductionPercentage	0.04	pure
CY2023	utme	Research And Development Superdeduction Percentage ResearchAndDevelopmentSuperdeductionPercentage	0.02	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.19	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.07	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0.02	pure
CY2021	utme	Total Income Tax Provision Percentage TotalIncomeTaxProvisionPercentage	0.02	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.50	pure
CY2023	us-gaap	Repayments Of Unsecured Tax Exempt Debt RepaymentsOfUnsecuredTaxExemptDebt	100000	cny
CY2022	utme	Due From Other Payble Related Parties DueFromOtherPaybleRelatedParties	1422000	cny
CY2023	utme	Revenues By Geography Information RevenuesByGeographyInformation	200547000	cny
CY2023	utme	Due From Other Payble Related Parties DueFromOtherPaybleRelatedParties	584000	cny
CY2022Q1	utme	Due To Related Parties Current And Non Current DueToRelatedPartiesCurrentAndNonCurrent	4499000	cny
CY2023Q1	utme	Due To Related Parties Current And Non Current DueToRelatedPartiesCurrentAndNonCurrent	5500000	cny
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	140000000	shares
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4517793	shares
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4517793	shares
CY2021Q2	utme	Public Price Per Share PublicPricePerShare	4
CY2021Q2	utme	Gross Proceeds GrossProceeds	15000000	usd
CY2021Q2	utme	Offering Fees And Expenses OfferingFeesAndExpenses	13900000	usd
CY2021Q2	utme	Offering Fees And Expenses OfferingFeesAndExpenses	88200000	cny
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	140000000	shares
CY2023Q1	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	8267793	shares
CY2023Q1	us-gaap	Excess Stock Shares Outstanding ExcessStockSharesOutstanding	8267793	shares
CY2022Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	5300000	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	5300000	shares
CY2023	us-gaap	Stock Granted During Period Value Sharebased Compensation StockGrantedDuringPeriodValueSharebasedCompensation	9301500000	usd
CY2023	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	1.755
CY2021	utme	Revenues By Geography Information RevenuesByGeographyInformation	246899000	cny
CY2022	utme	Revenues By Geography Information RevenuesByGeographyInformation	275508000	cny
CY2021	utme	Revenues By Geography Information RevenuesByGeographyInformation	246899000	cny
CY2022	utme	Revenues By Geography Information RevenuesByGeographyInformation	275508000	cny
CY2023	utme	Revenues By Geography Information RevenuesByGeographyInformation	200547000	cny
CY2022Q1	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	54589000	cny
CY2023Q1	us-gaap	Assets Held For Sale Long Lived Fair Value Disclosure AssetsHeldForSaleLongLivedFairValueDisclosure	74460000	cny
CY2022Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	2600000	cny
CY2023Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	1800000	cny
CY2022	us-gaap	Cash Dividends Paid To Parent Company CashDividendsPaidToParentCompany	71900000	cny
CY2023	us-gaap	Cash Dividends Paid To Parent Company CashDividendsPaidToParentCompany	72100000	cny
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	12618000	cny
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	32350000	cny
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	18396000	cny
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	4009000	cny
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	6483000	cny
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	69220000	cny
CY2021	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-16627000	cny
CY2022	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-38833000	cny
CY2023	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-87616000	cny
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-1868000	cny
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	377000	cny
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-2445000	cny
CY2021	utme	Comprehensive Income Net Of Taxes ComprehensiveIncomeNetOfTaxes	14759000	cny
CY2022	utme	Comprehensive Income Net Of Taxes ComprehensiveIncomeNetOfTaxes	39210000	cny
CY2023	utme	Comprehensive Income Net Of Taxes ComprehensiveIncomeNetOfTaxes	85171000	cny
CY2021	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	16627000	cny
CY2022	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	38833000	cny
CY2023	us-gaap	Income Loss From Equity Method Investments Net Of Dividends Or Distributions IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions	87616000	cny
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	12618000	cny
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	32350000	cny
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	18396000	cny
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	63656000	cny
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	8424000	cny
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1173000	cny
CY2021	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	12206000	cny
CY2022	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	8000000	cny
CY2023	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	1539000	cny
CY2021	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties	23000	cny
CY2021	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	131000	cny
CY2022	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	1269000	cny
CY2023	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	4026000	cny
CY2021	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	-119000	cny
CY2022	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1613000	cny
CY2023	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	1000	cny
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	125000	cny
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1618000	cny
CY2021	utme	Cash And Cash Equivalents Period Increase Decreased CashAndCashEquivalentsPeriodIncreaseDecreased	6000	cny
CY2022	utme	Cash And Cash Equivalents Period Increase Decreased CashAndCashEquivalentsPeriodIncreaseDecreased	-5000	cny
CY2023	utme	Cash And Cash Equivalents Period Increase Decreased CashAndCashEquivalentsPeriodIncreaseDecreased	1000	cny
CY2021Q1	us-gaap	Cash Cash	6000	cny
CY2022Q1	us-gaap	Cash Cash	1000	cny
CY2021Q1	us-gaap	Cash Cash	6000	cny
CY2022Q1	us-gaap	Cash Cash	1000	cny
CY2023Q1	us-gaap	Cash Cash	2000	cny
CY2023	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	19000000	cny
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments		cny
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		cny
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2022Q1	utme	Government Grant GovernmentGrant		cny
CY2021	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest		cny
CY2021	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest		cny
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.14
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.68
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.76
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.80
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11229985	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11229985	shares
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts		cny
CY2022	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal		cny
CY2023	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal		cny
CY2023	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal		usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation		cny
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation		cny
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		cny
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges		cny
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges		cny
CY2023	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		cny
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit		cny
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		cny
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue		cny
CY2021	utme	Increase Decrease In Government Grants IncreaseDecreaseInGovernmentGrants		cny
CY2022	utme	Increase Decrease In Government Grants IncreaseDecreaseInGovernmentGrants		cny
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		cny
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment		cny
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		cny
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		cny
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired		usd
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		cny
CY2023	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt		cny
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		cny
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		cny
CY2023	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts		usd
CY2021	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates		cny
CY2023	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates		cny
CY2023	us-gaap	Proceeds From Contributions From Affiliates ProceedsFromContributionsFromAffiliates		usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		cny
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		cny
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		cny
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		cny
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
CY2022	utme	Fack Mask FackMask		cny
CY2023	utme	Fack Mask FackMask		cny
CY2021	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-16267000	cny
CY2022	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-38833000	cny
CY2023	us-gaap	Net Income Loss From Continuing Operations Available To Common Shareholders Diluted NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted	-87616000	cny
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11229985	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4517793	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	8164771	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-3.68
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.76
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-7.80
CY2023	utme	Warrant Period WarrantPeriod	P1Y
CY2022Q1	us-gaap	Deferred Revenue And Credits DeferredRevenueAndCredits		cny
CY2023	us-gaap	Advertising Expense AdvertisingExpense		cny
CY2020Q1	utme	Statutory Reserve Funds StatutoryReserveFunds		cny
CY2022Q1	utme	Statutory Reserve Funds StatutoryReserveFunds		cny
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions		cny
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions		cny
CY2021	utme	Allowance For Doubtful Other Receivables Reversal AllowanceForDoubtfulOtherReceivablesReversal		cny
CY2023	utme	Allowance For Doubtful Other Receivables Reversal AllowanceForDoubtfulOtherReceivablesReversal		cny
CY2023	utme	Reversal Additions Debt For The Year ReversalAdditionsDebtForTheYear		cny
CY2023	utme	Debt Written Off For The Year DebtWrittenOffForTheYear		cny
CY2021	us-gaap	Finite Lived Intangible Assets Foreign Currency Translation Gain Loss FiniteLivedIntangibleAssetsForeignCurrencyTranslationGainLoss		cny
CY2023	us-gaap	Short Term Lease Cost ShortTermLeaseCost		cny
CY2022Q1	us-gaap	Equity Method Investments EquityMethodInvestments		cny
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments		cny
CY2023	utme	Prepayment For Property And Equipment And Intangible Asset PrepaymentForPropertyAndEquipmentAndIntangibleAsset		cny
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		cny
CY2023	us-gaap	Provision For Other Credit Losses ProvisionForOtherCreditLosses		cny
CY2021	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		cny
CY2023	us-gaap	Impairment Of Intangible Assets Excluding Goodwill ImpairmentOfIntangibleAssetsExcludingGoodwill		cny
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		cny
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit		cny
CY2021	us-gaap	Deferred Other Tax Expense Benefit DeferredOtherTaxExpenseBenefit		cny
CY2023Q1	us-gaap	Other Long Term Investments OtherLongTermInvestments		cny
CY2023Q1	utme	Unrealized Foreign Exchange Difference And Others UnrealizedForeignExchangeDifferenceAndOthers		cny
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate		pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes		pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes		pure
CY2022	utme	Total Income Tax Provision Percentage TotalIncomeTaxProvisionPercentage		pure
CY2023	utme	Total Income Tax Provision Percentage TotalIncomeTaxProvisionPercentage		pure
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation		cny
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation		cny
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense		cny
CY2022	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		cny
CY2023	us-gaap	Increase Decrease In Due From Related Parties IncreaseDecreaseInDueFromRelatedParties		cny
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations		cny
CY2020Q1	us-gaap	Cash Cash		cny
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001789299

Files In Submission

Name	View Source	Status
0001213900-23-064327-index-headers.html	Edgar Link	pending
0001213900-23-064327-index.html	Edgar Link	pending
0001213900-23-064327.txt	Edgar Link	pending
0001213900-23-064327-xbrl.zip	Edgar Link	pending
ex15-1_001.jpg	Edgar Link	pending
ex15-2_001.jpg	Edgar Link	pending
ex15-2_002.jpg	Edgar Link	pending
ex15-3_001.jpg	Edgar Link	pending
f20f2023ex12-1_utimelimited.htm	Edgar Link	pending
f20f2023ex12-2_utimelimited.htm	Edgar Link	pending
f20f2023ex13-1_utimelimited.htm	Edgar Link	pending
f20f2023ex13-2_utimelimited.htm	Edgar Link	pending
f20f2023ex15-1_utimelimited.htm	Edgar Link	pending
f20f2023ex15-2_utimelimited.htm	Edgar Link	pending
f20f2023ex15-3_utimelimited.htm	Edgar Link	pending
f20f2023ex19-1_utimelimited.htm	Edgar Link	pending
f20f2023ex4-59_utimelimited.htm	Edgar Link	pending
f20f2023ex4-60_utimelimited.htm	Edgar Link	pending
f20f2023ex4-61_utimelimited.htm	Edgar Link	pending
f20f2023ex4-62_utimelimited.htm	Edgar Link	pending
f20f2023ex4-63_utimelimited.htm	Edgar Link	pending
f20f2023ex4-64_utimelimited.htm	Edgar Link	pending
f20f2023ex4-65_utimelimited.htm	Edgar Link	pending
f20f2023ex4-66_utimelimited.htm	Edgar Link	pending
f20f2023ex4-67_utimelimited.htm	Edgar Link	pending
f20f2023ex4-68_utimelimited.htm	Edgar Link	pending
f20f2023ex4-69_utimelimited.htm	Edgar Link	pending
f20f2023_utimelimited.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f20f2023_utimelimited_htm.xml	Edgar Link	completed
image_003.jpg	Edgar Link	pending
image_004.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
utme-20230331.xsd	Edgar Link	pending
utme-20230331_def.xml	Edgar Link	unprocessable
utme-20230331_lab.xml	Edgar Link	unprocessable
utme-20230331_pre.xml	Edgar Link	unprocessable
utme-20230331_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$WTO
UTime Ltd Stock $wto

2023 Q3 Form 20-F Financial Statement

#000121390023064327 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WTO UTime Ltd Stock $wto

2023 Q3 Form 20-F Financial Statement

#000121390023064327 Filed on August 08, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$WTO
UTime Ltd Stock $wto